BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
LEAD Therapeutics raises $17 million in Series A financing
News | 11. 05. 2007
LEAD Therapeutics
LEAD Therapeutics, Inc., a chemistry-driven drug discovery company, today announced it has raised $17 million in Series A financing co-led by Pappas Ventures and ProQuest Investments. Also participating in this financing round is Mustang Ventures, a China-focused venture firm.
